Report overview
Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.
This report contains market size and forecasts of Barbiturate Drugs in global, including the following market information:
Global Barbiturate Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Barbiturate Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Barbiturate Drugs companies in 2021 (%)
The global Barbiturate Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ultra-Short Acting Barbiturate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Barbiturate Drugs include Pfizer, Merck, Eli Lilly, Mylan, Sanofi, Teva Pharmaceutical, Sumitomo Dainippon Pharma, Bausch Health and Oak Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Barbiturate Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Barbiturate Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Barbiturate Drugs Market Segment Percentages, by Type, 2021 (%)
Ultra-Short Acting Barbiturate
Short-Acting Barbiturate
Long-Acting Barbiturate
Combination Drugs
Global Barbiturate Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Barbiturate Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Barbiturate Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Barbiturate Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Barbiturate Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Barbiturate Drugs revenues share in global market, 2021 (%)
Key companies Barbiturate Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Barbiturate Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
Eli Lilly
Mylan
Sanofi
Teva Pharmaceutical
Sumitomo Dainippon Pharma
Bausch Health
Oak Pharmaceuticals
Meda pharmaceuticals
